Skip to main content

Table 3 Logistics regression for postoperative high-output fistula after PSM

From: Effect of postoperative utilization of somatostatin on clinical outcome after definitive surgery for duodenal fistula

 

OR

95% CI

P

OR

95% CI

P

Male

2.31

0.77–6.96

0.13

   

Postoperative usage of somatostatin

0.33

0.11–0.99

0.04

0.30

0.09–0.95

0.04

Age

0.98

0.95–1.02

0.33

   

BMI

1.02

0.73–1.43

0.91

   

Anatomy of fistula

 Stump

Ref

     

 Bulb or descending portion

2.11

0.68–6.53

0.19

   

 Pars horizontalis duodeni

4.80

0.69–33.11

0.11

   

Etiology

 Upper gastrointestinal tract tumor

Ref

  

Ref

  

 Trauma

1.53

0.38–6.06

0.55

1.49

0.37–6.05

0.57

 Pancreatitis

4.62

0.99–21.34

0.05

5.05

1.05–24.36

0.04

 High output

0.54

1.95–1.52

0.24

   

 Combined with abdominal hernia

0.80

0.36–1.81

0.59

   

Preoperative hemoglobin

  ≥ 120 g/L

Ref

     

  > 100 g/L, and < 120 g/L

1.29

0.47–3.56

0.62

   

Preoperative albumin

  ≥ 35 g/L

Ref

     

  > 30 g/L, and < 35 g/L

0.48

0.33–1.19

0.17

   

Glutamic pyruvic transaminase

 Creatinine

 Blood loss

   < 1000 mL

Ref

     

   ≥ 1000 mL

1.27

0.47–3.45

0.64

   

  Glutamic pyruvic transaminase

1.05

0.74–1.18

0.72

   

  Total bilirubin

0.96

0.52–1.39

0.49

   

  Creatinine

0.99

0.61—1.24

0.67

   

Duration of definitive surgery

  < 4 h

Ref

     

  ≥ 4 h

1.65

0.61—4.52

0.33

   

Surgical procedure

 Suture

Ref

     

 Duodenojejunostomy Roux-en-Y

1.05

0.361—3.03

0.94

   

Required blood transfusion within 48 h after definitive surgery

  < 1000 mL

Ref

     

  ≥ 1000 mL

1.76

0.64—4.82

0.27

   

Required albumin transfusion within 48 h after definitive surgery

  < 100 g

Ref

     

  ≥ 100 g

1.91

0.69—5.33

0.22

   

 Hypertension

5.94

0.35—99.58

0.22

   

 Diabetes mellitus

2.00

0.37—10.79

0.42